Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer: Molecular Therapy - Oncolytics
Gl261 Cell Lines | Bioz | Ratings For Life-Science Research
A therapeutic cancer vaccine against GL261 murine glioma | Journal of Translational Medicine | Full Text
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy - Szatmári - 2006 - Cancer Science - Wiley Online Library
Biomolecules | Free Full-Text | Targeted Delivery of Nanoparticulate Cytochrome C into Glioma Cells Through the Proton-Coupled Folate Transporter
The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity - ScienceDirect
GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models | Scientific Reports
Romo1 is involved in the immune response of glioblastoma by regulating the function of macrophages | Aging
GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models | Scientific Reports
PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients | Journal of Neuroscience
German Collection of Microorganisms and Cell Cultures GmbH: Details
PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients | Journal of Neuroscience
Frontiers | Peptide Vaccine Combined Adjuvants Modulate Anti-tumor Effects of Radiation in Glioblastoma Mouse Model
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer: Molecular Therapy - Oncolytics
Implantation of GL261 neurospheres into C57/BL6 mice: A more reliable syngeneic graft model for research on glioma-initiating cells
The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8+T Cell Anti-tumor Activity - ScienceDirect
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy - Szatmári - 2006 - Cancer Science - Wiley Online Library
The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells | PLOS ONE
German Collection of Microorganisms and Cell Cultures GmbH: Details
GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models | Scientific Reports
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are surviva
A therapeutic cancer vaccine against GL261 murine glioma | Journal of Translational Medicine | Full Text